Effects of fenugreek, Nigella, and termis seeds in nonalcoholic fatty liver in obese diabetic albino rats

Arab Journal of Gastroenterology

Volumn 16, Issue 1, 2015, Pages 1-9

  Mohamed, Waleed S ^a,b   Mostafa, Ashraf M ^a   Mohamed, Khaled M ^a   Serwah, Abdel Hamid ^a  

^a TAIF UNIVERSITY   (Saudi Arabia)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

Alloxan; Antidiabetic plants; Diabetes; Nonalcoholic fatty liver diseases; Pancreas

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FENUGREEK EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN; NIGELLA SATIVA EXTRACT; TERMIS EXTRACT; UNCLASSIFIED DRUG; ALLOXAN; FENUGREEK SEED MEAL; PLANT EXTRACT;

ADULT; ALBINO RAT; ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL ANALYSIS; BLACK CUMIN; CELL REGENERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MIXTURE; DYSLIPIDEMIA; FENUGREEK; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PANCREAS ISLET BETA CELL; PLANT SEED; PRIORITY JOURNAL; RAT; TERMIS; ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; HUMAN; INBRED RAT STRAIN; METABOLISM; NIGELLA; NON-ALCOHOLIC FATTY LIVER DISEASE; NONPARAMETRIC TEST; OBESITY; PATHOLOGY; PHYTOTHERAPY; PROCEDURES; RANDOMIZATION; SAUDI ARABIA; TREATMENT OUTCOME; TRIGONELLA;

ADIPOSE TISSUE; ALLOXAN; ANALYSIS OF VARIANCE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; HUMANS; MALE; NIGELLA; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; SAUDI ARABIA; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TRIGONELLA;

EID: 84942987859     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2014.12.003     Document Type: Article

References (40)

1. Schreuder T, Verwer B, Nieuwkerk C, Mulder C. Nonalcoholic fatty liver disease. World J Gastroenterol 2008;14(16):2474-86.
2. Takuma Y, Nouso K. Nonalcoholic steatohepatitis-associated hepatocellular Carcinoma. World J Gastroenterol 2010;16(12):1436-41.
3. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99e112.
4. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132e8.
5. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-8.
6. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
7. Edmison J, Arthur M, McCullough J. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 2007;11:75-104.
8. Alba LM, Lindor K. Review article: non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2003;17:977-86.
9. Kaleem M, Kirmani D, Asif M, Ahmed Q. Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J Exp Biol 2006;44(9):745-8.
10. Hongxiang H, Vay Liang W. Hypoglycemic herbs and their action mechanisms. Chin Med 2009;4:11-4.
11. Al-Habbori M, Raman A. Antidiabetic and hypocholesterolemic effects of fenugreek. Phytother Res 1998;12:233-42.
12. Knecht K, Nguyen H, Auker A, Kinder D. Effects of extracts of lupine seed on blood glucose levels in glucose resistant mice: antihyperglycemic effects of Lupinus albus (white lupine, Egypt) and Lupinus caudatus. J Herb Pharmacother 2006;6(3-4):89-104.
13. Wadkar K, Magdum C, Patil S, Naikwade N. Antidiabetic potential and Indian medicinal plants. J Herb Med Toxicol 2008;2:45-50.
14. Randy J, Paul A, David DA, Patrick T. A controlled high-fat diet induces an obese syndrome in rats. The American Society for Nutritional Sciences; 2003.
15. ShiffT, Roheim PS, Eder H. Effects of high sucrose diets and 4-aminopyrazolopyrimidine on serum lipids and lipoproteins in the rat. J Lipid Res 1971;12:596-603.
16. Angel I. The use of microtiter plates for the simple and sensitive determination of insulin by an ELISA method. Experientia 1988;44:877-9.
17. Halami N. Differentiation of the two types of basophiles in an adenohypophysis of the rat and the mouse. Stain Technol 1952;27:61.
18. Sokal R, Rahif F. The principles and practical of statistic in biological research. 2nd ed. San Francisco: CA, W.H. Freeman and Company; 1981.
19. Policlinico Orsola S, Via Massarenti. Diabetes and liver disease: an ominous association. Nutr Metab Cardiovasc Dis 2007;17:63-70.
20. Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 2007;11(1):75-104.
21. Ashraf M, Abdel Hamid S, Waleed S, Khaled M. Effects of some antidiabetic medicinal plants on pancreas and liver of diabetic Albino rats. Egypt J Hosp Med 2013 Jan;50:156-68.
22. Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Invest 2014;5:349-58.
23. Cao L, Liu X, Cao H, Qingguo L, Tong N. Modified highsucrose diet-induced abdominally obese and normal-weight rats developed high plasma free. Oxidative Medicine and Cellular Longevity 2012:1-9.
24. Abdel-Moneim A, El-Feki M, Salah E. Effect of Nigella Sativa, fish oil and gliclazide on Alloxan-diabetic rats. Biochemical and histopathological studies. J Egypt Ger Soc Zool 1999;23(A):237-65.
25. Ganong W. Review of medical physiology. 23rd ed. New York: Lange Med. Public; 2003. p. 306-26 (Chapter 19).
26. Helal E, Hasan M, Mustafa A, Al-Kamel A. Effect of Aloe Vera extract on some physiological parameters in diabetic albino rats. Egypt J Hosp Med 2003;12:53-61.
27. Guyton A, Hall J. Text book of medical physiology. Endocrinology and reproduction. In: Insulin, Glucagon and Diabetes Mellitus. 2000; 10th ed., USA:W.B. Sounders Company.
28. Kavishankar G, Lakshmidevi N, Mahadeva M, Prakash H. Diabetes and medicinal plants-a review. Int J Pharm Biomed Sci 2011;2(3):65-80.
29. Meral I, Yener Z, Kahraman T, Mert N. Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defense system and liver damage in experimentally induced diabetic rabbits. J Vet Med A Physiol Pathol Clin Med 2001;48(10):593-9.
30. Shafrir E. Diabetes in animals: Contribution to the understanding of diabetes by study of its etiopathology in animal models. Biennial review. SmithGordon, 2003; pp.: 231-235.
31. Augusti K, Sheela G. Theory and practice of histological techniques. 4th ed. Edinburgh and London: Churchill Living; 1996. p. 123.
32. Zahida T, Zeshan S, Nisar A, Mushtaq H. The effects of Nigella sativa (kalonji) on lipid profile in patients with stable coronary artery disease in multan, Pakistan. Pak J Nutr 2011;10(2):162-7.
33. Akash M, Rehman F, Sethi A, Abrar M, Irshad A, Abid A, et al. Alternate therapy of Type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae). J Med Plants Res 2011;5(31):6885-9.
34. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286-92.
35. Ebihara K, Ogawa Y, Masuzaki H. Transgenic over expression of Leptin rescues insulin resistance and diabetes in a mouse model of Lipoatrophic diabetes. Diabetes 2001;50(6):1140.
36. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-8.
37. Martin A, Marja-Riitta T, Jan B. Fatty liver, insulin resistance, and dyslipidemia. Curr Diabetes Rep 2008;8(1):60-4.
38. Levinthal GN, Tavill AS. Liver disease and diabetes mellitus. Clinical diabetes 1999;17(2):73-7.
39. Marchesini G, Forlani G, Bugianesi E. Is liver disease a threat to patients with metabolic disorders? Ann Med 2005;37:333-46.
40. Calle E, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.